Discover the Divis Labs Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Divi's Laboratories faces a ₹570 crore draft tax assessment for FY23, citing Transfer Pricing and corporate tax adjustments.

Join us on the Divis Labs Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock.

Divi’s Laboratories has received a draft tax assessment order proposing ₹570.51 crore in additions to FY23 income due to ...

Divi’s Labs could emerge as a key beneficiary of the global GLP-1 drug boom, with new peptide manufacturing contracts and ...

Mumbai: Divi's Laboratories Ltd has received a draft assessment order from the Income Tax Department proposing additions and ...

Stocks including HDFC Bank, Tata Steel, RITES, Union Bank, Divis Labs, Metropolis, DCX Systems, TMPV, Ashok Leyland and more ...

HYDERABAD, Aug 14 (Reuters) - Indian pharmaceutical company Divi's Laboratories (DIVI.NS), opens new tab reported a 49.2% fall in quarterly profit, missing analysts' estimates, as the generic drug ...

On Monday, Nifty 50 closed flat at 24,836.10. The benchmark index however hit an all-time high of 24,999.75. Leading the gains, Divis Laboratories topped the charts with a 2.78% rise in its stock ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey BENGALURU (Reuters) - Shares of ...

HYDERABAD, Feb 3 (Reuters) - India's Divi's Laboratories (DIVI.NS), opens new tab reported a better-than-expected quarterly profit on Monday, aided by strong performance of its business that focuses ...